Obesity
Overview
Obesity is defined as having an excessive amount of body fat.
Obesity increases risk of diseases and health problems such as heart disease,
diabetes and high blood pressure. The predisposing factors include age, family
history, quitting smoking, lack of sleep and certain medications. Treatment
includes healthy lifestyle, medications and surgery.
Click here for sample
report @ http://www.wiseguyreports.com/sample-request/1306991-obesity-pipeline-review-h1-2017
Obesity Industry Major Outlook
The Pharmaceutical and Healthcare latest pipeline guide
Obesity - Pipeline Review, H1 2017, provides comprehensive information on the
therapeutics under development for Obesity (Metabolic Disorders), complete with
analysis by stage of development, drug target, mechanism of action (MoA), route
of administration (RoA) and molecule type. The guide covers the descriptive
pharmacological action of the therapeutics, its complete research and
development history and latest news and press releases.
The Obesity (Metabolic Disorders) pipeline guide also reviews
of key players involved in therapeutic development for Obesity and features
dormant and discontinued projects. The guide covers therapeutics under
Development by Companies /Universities /Institutes, the molecules developed by
Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II,
Phase I, Preclinical, Discovery and Unknown stages are 1, 1, 3, 16, 22, 129, 30
and 1 respectively. Similarly, the Universities portfolio in Phase I,
Preclinical and Discovery stages comprises 1, 50 and 14 molecules,
respectively.
Obesity (Metabolic Disorders) pipeline guide helps in
identifying and tracking emerging players in the market and their portfolios,
enhances decision making capabilities and helps to create effective counter
strategies to gain competitive advantage. Additionally, various dynamic
tracking processes ensure that the most recent developments are captured on a
real time basis.
Obesity - Competitive Analysis
Key players are making innovative developments in Obesity industry. The same will help in improving the market
performance. Heavy investments are made by major players in the R&D sector
Scope
- The pipeline guide provides a snapshot of the global
therapeutic landscape of Obesity (Metabolic Disorders).
- The pipeline guide reviews pipeline therapeutics for Obesity (Metabolic Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Obesity (Metabolic Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Obesity (Metabolic Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Obesity (Metabolic Disorders)
- The pipeline guide reviews pipeline therapeutics for Obesity (Metabolic Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Obesity (Metabolic Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Obesity (Metabolic Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Obesity (Metabolic Disorders)
.Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1306991-obesity-pipeline-review-h1-2017
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt.
Ltd. and offers premium progressive statistical surveying, market research
reports, analysis & forecast data for industries and governments around the
globe. Wise Guy Reports understand how essential statistical surveying
information is for your organization or association. Therefore, we have
associated with the top publishers and research firms all specialized in
specific domains, ensuring you will receive the most reliable and up to date
research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
No comments:
Post a Comment